This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Ivo Eggen, PhD
Section Lead New Product Development at Aspen Oss B.V.

Profile

Working for Aspen and its predecessors for almost 22 years. Leader of Technical Support / Process Development department: responsible for development of new methodologies for peptide synthesis and DSP, development of new small molecule synthesis & DSP routes, production of development & validation batches, manufacturing support, process surveillance, trouble shooting, external relocations (outsourcing & tech transfer), project & change management, QbD. Responsible for compliance of the departmental activities with SHE, quality/GMP and SOX regulations. Coordinating function with Manufacturing, Supply Chain, Marketing & Sales, Purchasing, Intellectual Property, Quality and Regulatory departments, contract manufacturers and customers.

Agenda Sessions

  • Aspen’s Green Continuous LPPS Method for the Manufacturing of Lanreotide: Control Strategy Considerations

    14:00

Speakers at this event